Citadel Advisors’s Calumet Specialty Products CLMT Stock Holding History

Citadel Advisors’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$33.5M	Sell	932,200 -225,200	-19%	-$5.83M	0.01%	1742
2025 Q4	$23M	Buy	1,157,400 +266,200	+30%	+$5.12M	﹤0.01%	2183
2025 Q3	$16.3M	Buy	891,200 +183,300	+26%	+$3.02M	﹤0.01%	2594
2025 Q2	$11.2M	Buy	707,900 +132,300	+23%	+$1.68M	﹤0.01%	2880
2025 Q1	$7.3M	Sell	575,600 -112,400	-16%	-$1.77M	﹤0.01%	3306
2024 Q4	$15.1M	Buy	688,000 +21,400	+3%	+$450K	﹤0.01%	2477
2024 Q3	$11.9M	Buy	666,600 +512,900	+334%	+$8.22M	﹤0.01%	2661
2024 Q2	$2.47M	Sell	153,700 -78,500	-34%	-$1.24M	﹤0.01%	4923
2024 Q1	$3.45M	Sell	232,200 -113,600	-33%	-$1.81M	﹤0.01%	4560
2023 Q4	$6.18M	Buy	345,800 +4,400	+1%	+$71.4K	﹤0.01%	3507
2023 Q3	$6.52M	Buy	341,400 +33,900	+11%	+$587K	﹤0.01%	3264
2023 Q2	$4.88M	Sell	307,500 -122,300	-28%	-$2.01M	﹤0.01%	3693
2023 Q1	$7.47M	Buy	429,800 +170,300	+66%	+$3.02M	﹤0.01%	3191
2022 Q4	$4.38M	Buy	259,500 +120,300	+86%	+$1.94M	﹤0.01%	4079
2022 Q3	$1.78M	Buy	139,200 +6,600	+5%	+$94.7K	﹤0.01%	5809
2022 Q2	$1.38M	Buy	132,600 +11,900	+10%	+$158K	﹤0.01%	6307
2022 Q1	$1.64M	Sell	120,700 -87,800	-42%	-$1.29M	﹤0.01%	6528
2021 Q4	$2.75M	Buy	208,500 +172,400	+478%	+$2.17M	﹤0.01%	5510
2021 Q3	$286K	Buy	36,100 +2,900	+9%	+$20K	﹤0.01%	11144
2021 Q2	$228K	Sell	33,200 -45,400	-58%	-$280K	﹤0.01%	11877
2021 Q1	$479K	Buy	78,600 +36,700	+88%	+$153K	﹤0.01%	9766
2020 Q4	$131K	Buy	41,900 +8,300	+25%	+$28.9K	﹤0.01%	10034
2020 Q3	$86K	Sell	33,600 -174,800	-84%	-$449K	﹤0.01%	9357
2020 Q2	$475K	Buy	208,400 +126,500	+154%	+$270K	﹤0.01%	7169
2020 Q1	$86K	Sell	81,900 -49,500	-38%	-$167K	﹤0.01%	8723
2019 Q4	$480K	Buy	131,400 +13,900	+12%	+$48K	﹤0.01%	6867
2019 Q3	$428K	Buy	117,500 +10,400	+10%	+$44.5K	﹤0.01%	7000
2019 Q2	$449K	Sell	107,100 -26,800	-20%	-$107K	﹤0.01%	6987
2019 Q1	$477K	Sell	133,900 -87,600	-40%	-$291K	﹤0.01%	6864
2018 Q4	$490K	Buy	221,500 +98,800	+81%	+$408K	﹤0.01%	6420
2018 Q3	$785K	Buy	122,700 +63,300	+107%	+$449K	﹤0.01%	5954
2018 Q2	$443K	Buy	59,400 +36,200	+156%	+$272K	﹤0.01%	6568
2018 Q1	$164K	Sell	23,200 -700	-3%	-$5.17K	﹤0.01%	7487
2017 Q4	$184K	Sell	23,900 -6,300	-21%	-$52.5K	﹤0.01%	7167
2017 Q3	$252K	Buy	+30,200	New	+$188K	﹤0.01%	6332
2016 Q3	–	Sell	-22,200	Closed	-$109K	–	7273
2016 Q2	$109K	Buy	22,200 +7,000	+46%	+$39.7K	﹤0.01%	6151
2016 Q1	$179K	Buy	15,200 +9,700	+176%	+$135K	﹤0.01%	5711
2015 Q4	$110K	Buy	5,500 +1,000	+22%	+$24.7K	﹤0.01%	6576
2015 Q3	$109K	Sell	4,500 -3,500	-44%	-$90.9K	﹤0.01%	6874
2015 Q2	$204K	Buy	8,000 +5,500	+220%	+$146K	﹤0.01%	6292
2015 Q1	$60K	Sell	2,500 -900	-26%	-$22.8K	﹤0.01%	7261
2014 Q4	$76K	Buy	3,400 +600	+21%	+$15.6K	﹤0.01%	6882
2014 Q3	$77K	Sell	2,800 -1,300	-32%	-$39.3K	﹤0.01%	6614
2014 Q2	$130K	Sell	4,100 -3,100	-43%	-$92.2K	﹤0.01%	5997
2014 Q1	$186K	Buy	7,200 +5,400	+300%	+$147K	﹤0.01%	5587
2013 Q4	$47K	Sell	1,800 -4,500	-71%	-$126K	﹤0.01%	6080
2013 Q3	$172K	Sell	6,300 -11,900	-65%	-$374K	﹤0.01%	4905
2013 Q2	$662K	Buy	+18,200	New	+$654K	﹤0.01%	3570

Other funds holding CLMT

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WDOM

Wasserstein Debt Opportunities Management New York $189M AUM 169.75% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Citadel Advisors's CLMT Position: Q1 2026 in Review

Citadel Advisors opened a new position in Calumet Specialty Products (CLMT) in Q1 2026: 536,033 shares worth $19.2M. The stake represents ﹤0.01% of the portfolio and ranks #2383 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in CLMT as recently as Q3 2025.

Citadel Advisors first reported a position in CLMT in Q2 2013 and has held it in 45 quarters since. 180 funds tracked by Wall St. Rank hold CLMT as of Q1 2026.

Citadel Advisors held 536,033 shares of Calumet Specialty Products worth $19.2M as of Q1 2026.
Calumet Specialty Products was a new Citadel Advisors position in Q1 2026.
Calumet Specialty Products made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2383 holding.
Citadel Advisors first reported a position in Calumet Specialty Products in Q2 2013 and has held it in 45 quarters since.
180 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.